Cell Surface Glycan Modification Research: Glycosyltransferases, Glycosidases, and Glycocalyx Functional Analysis

Cell surface glycan modification research is mainly used to analyze how glycosylation structures on glycoproteins, glycolipids, and proteoglycans affect cell recognition, adhesion, migration, immune regulation, and receptor signaling. In experiments, it is not enough to detect glycan distribution alone; the roles of glycosyltransferases, glycosidases, and glycosaminoglycan lyases in glycan formation, removal, and functional validation should also be considered.

Keywords: cell surface glycan modification; glycocalyx; glycosyltransferase; glycosidase; sialylation; fucosylation; lectin probe; glycomics

1 Research Positioning of Cell Surface Glycan Modification

1.1 Structural Basis of Cell Surface Glycans

(1) Glycoprotein glycans

N-glycans and O-glycans on membrane proteins are major components of cell surface glycan modifications. N-glycans often affect receptor folding, membrane localization, ligand binding, and endocytic turnover. O-glycans are commonly found on mucins, receptor extracellular regions, and adhesion molecules, where they can alter the cell surface barrier, antigen exposure, and intercellular interactions. Glycan branching, terminal sialylation, fucosylation, and galactosylation status usually provide stronger functional interpretation than a single monosaccharide residue.

(2) Glycolipid glycans

Glycolipid glycans are located in lipid rafts and membrane microdomains and participate in membrane organization, receptor clustering, and pathogen binding. Gangliosides, globosides, and lacto-series glycolipids can be studied in relation to cell differentiation, neural development, tumor phenotype, and infection receptors. Glycolipid glycan function should not be interpreted separately from the membrane lipid environment, but should be analyzed together with membrane microdomains, receptor signaling, and cellular state.

(3) Proteoglycans and glycosaminoglycans

Cell surface proteoglycans consist of core proteins and glycosaminoglycan chains. Common glycosaminoglycans include heparan sulfate, chondroitin sulfate, dermatan sulfate, and hyaluronan-related structures. Their primary role is not simply to increase glycan abundance, but to regulate binding to growth factors, chemokines, viral particles, and extracellular matrix molecules through negative charge, sulfation sites, and spatial extension.

1.2 Core Roles of Enzymes in Glycan Modification Research

(1) Synthetic enzymes determine glycan structural direction

Glycosyltransferases determine the order of monosaccharide addition, linkage type, and terminal modification pattern. For example, sialyltransferases determine α2,3 or α2,6 sialylation, fucosyltransferases determine core fucosylation or terminal fucosylation, and N-acetylglucosaminyltransferases and galactosyltransferases affect N-glycan branching and LacNAc extension.

(2) Hydrolases are used for structural validation

Glycosidases and glycosaminoglycan lyases are often used to validate the origin of glycan detection signals. Neuraminidase can verify sialic acid-related lectin signals. PNGase F can be used for N-glycan release and deglycosylation analysis. Heparinase and chondroitinase can validate the role of cell surface glycosaminoglycans in ligand binding, viral attachment, and cell migration.

(3) Enzymatic intervention connects structure and function

Lectin signal detection alone only indicates that glycan-binding sites have changed; it does not directly prove a functional mechanism. A more reliable relationship between glycan structure and functional phenotype can be established when cell adhesion, migration, immune recognition, or receptor signaling changes simultaneously after glycosidase treatment, glycosyltransferase knockdown, or recombinant enzyme modification.

Table 1 Cell Surface Glycan Modification Types and Key Enzymes

Glycan modification type	Main structural features	Related enzyme types	Research applications
N-glycosylation	High-mannose, hybrid, and complex N-glycans	PNGase F, Endo H, MGAT transferases	Receptor maturation, membrane localization, glycoproteomics
O-glycosylation	Mucin-type O-glycans, T/Tn-related structures	O-glycosidase, GALNT, C1GALT1	Mucin barrier, tumor glycoantigens, cell adhesion
Sialylation	Terminal sialic acid, often forming a negative charge barrier	Neuraminidase, ST3GAL, ST6GAL	Siglec binding, immune escape, viral receptors
Fucosylation	Core or terminal fucose structures	α-L-Fucosidase, FUT8, FUT7/FUT9	Selectin ligands, antibody Fc function, tumor glycans
Galactosylation	Terminal galactose or LacNAc structures	β-Galactosidase, B4GALT	Galectin binding, inflammatory regulation, receptor clustering
Glycosaminoglycan modification	Sulfated, polyanionic long-chain structures	Heparinase, chondroitinase, hyaluronidase, sulfatase	Growth factor binding, matrix interaction, infection and migration

2 Glycan Synthesis-Related Enzymes and Cell Surface Glycan Formation

2.1 N-Glycan Branching and Maturation

(1) N-glycan processing

N-glycans are initiated in the endoplasmic reticulum and further modified in the Golgi apparatus to form complex or hybrid structures. Glycosidases participate in early trimming, while N-acetylglucosaminyltransferases, mannosidases, galactosyltransferases, fucosyltransferases, and sialyltransferases jointly determine mature glycan structures. The maturation state of N-glycans on cell surface receptors affects receptor stability, membrane retention time, and ligand responsiveness.

(2) MGAT enzymes and branching structures

MGAT family N-acetylglucosaminyltransferases participate in the formation of complex N-glycan branches. Increased branching can enhance the potential for LacNAc extension and strengthen Galectin-mediated receptor clustering on the membrane surface. In studies of tumors, immune cell activation, and growth factor signaling, N-glycan branching is often associated with sustained receptor signaling and altered migratory capacity.

2.2 O-Glycan Initiation and Extension

(1) GALNT family

Polypeptide N-acetylgalactosaminyltransferases catalyze the initiation of mucin-type O-glycosylation by adding GalNAc to Ser/Thr residues on proteins. GALNT family members have substrate selectivity, and changes in different members can lead to Tn antigen exposure, altered mucin structure, and tumor glycoantigen formation.

(2) C1GALT1 and Core structure maturation

C1GALT1 participates in Core 1 O-glycan formation. When its function is insufficient, immature O-glycan structures may accumulate. O-glycan maturation status affects the cell surface mucin barrier, immune recognition, and extracellular matrix interaction. When studying O-glycans, glycosyltransferase expression, glycoantigen detection, and functional phenotypes should be considered together.

2.3 Terminal Modification Enzymes

(1) Sialyltransferases

ST3GAL and ST6GAL participate in α2,3 and α2,6 sialylation, respectively. Increased sialylation can enhance cell surface negative charge and alter lectin binding, Siglec recognition, and pathogen binding. Different sialic acid linkages have distinct functions, so all results should not be summarized simply as “total sialylation.”

(2) Fucosyltransferases

FUT8 participates in core α1,6 fucosylation of N-glycans, while FUT7, FUT9, and related enzymes participate in terminal fucosylation and selectin ligand-related structure formation. Core fucosylation often affects receptor or antibody function, whereas terminal fucosylation is more closely related to cell adhesion, inflammatory migration, and Lewis antigens.

(3) Galactosyltransferases and GlcNAc transferases

B4GALT enzymes participate in galactose addition, while GlcNAc transferases participate in LacNAc chain extension. LacNAc structures can serve as Galectin-binding platforms and affect receptor clustering, membrane retention, and the duration of cell signaling.

Table 2 Enzymes Related to Cell Surface Glycan Synthesis and Their Research Significance

Enzyme type	Main function	Affected glycan structure	Research significance
MGAT transferases	Promote N-glycan branching	Complex N-glycans	Receptor membrane retention, Galectin lattice, tumor migration
GALNT family	Initiate O-GalNAc glycosylation	Mucin-type O-glycans	Tn antigen, mucus barrier, tumor glycoantigens
C1GALT1	Forms Core 1 O-glycans	T antigen-related structures	O-glycan maturation, cell adhesion
ST3GAL	Adds α2,3 sialic acid	α2,3-sialylated glycans	MAL II signal, infection receptors, migration
ST6GAL1	Adds α2,6 sialic acid	α2,6-sialylated glycans	SNA signal, immune regulation, receptor stability
FUT8	Adds core fucose	Core α1,6-fucosylated N-glycans	Receptor function, antibody Fc glycosylation
FUT7/FUT9	Adds terminal fucose	Lewis/sLeX-related structures	Selectin binding, leukocyte migration
B4GALT	Adds β1,4 galactose	LacNAc extension	Galectin binding, membrane receptor clustering

3 Validation Roles of Glycosidases and Glycosaminoglycan Lyases

3.1 N-Glycan and O-Glycan Processing Enzymes

(1) PNGase F

PNGase F releases most N-glycans and is commonly used for glycoprotein deglycosylation, N-glycomics, and analysis of glycoprotein mobility shifts. For membrane protein studies, PNGase F is more suitable for lysates or purified glycoproteins. Direct use on live cell surfaces usually involves substrate accessibility limitations and interference from cellular state.

(2) Endo H

Endo H mainly acts on high-mannose and some hybrid N-glycans and can be used to determine whether a glycoprotein has completed Golgi maturation. If a membrane receptor is sensitive to Endo H, it usually indicates insufficient glycan maturation or retention in the early secretory pathway.

(3) O-glycosidase

O-glycosidase is used to remove specific core O-glycans. Terminal sialic acid or other modifications often need to be removed first to expose the core structure. Its results should be interpreted together with sialidase treatment, O-glycan antibodies, or mass spectrometry analysis.

3.2 Terminal Sugar-Residue Cleaving Enzymes

(1) Neuraminidase

Neuraminidase removes sialic acid residues and is an important tool for validating sialic acid-related signals from SNA, MAL II, WGA, and other lectins. Broad-spectrum neuraminidases are suitable for validating total sialic acid dependency, while linkage-specific neuraminidases can further distinguish α2,3 or α2,6 sialylation.

(2) Fucosidase

α-L-Fucosidase can remove terminal fucose structures and helps validate AAL, UEA-I, and related lectin signals. Core α1,6 fucosylation usually requires more specific core fucose-cleaving tools or glycoprotein mass spectrometry for confirmation.

(3) Galactosidases and HexNAc hydrolases

β-Galactosidase, α-galactosidase, β-N-acetylglucosaminidase, and related enzymes can be used to validate terminal galactose, GlcNAc, or GalNAc-related structures. A decrease in lectin signal after such enzyme treatment does not necessarily indicate complete loss of a single glycan, but rather that the target binding site or related terminal structure has been altered.

3.3 Glycosaminoglycan Lyases

(1) Heparinases

Heparinase I, II, and III cleave different sulfation regions of heparin/heparan sulfate and are commonly used to analyze the role of cell surface HS in growth factor binding, viral attachment, chemokine presentation, and receptor cooperation. Different heparinases have different substrate preferences, and experiments often use single-enzyme or combined-enzyme treatment.

(2) Chondroitinases

Chondroitinase ABC broadly degrades chondroitin sulfate and dermatan sulfate, whereas chondroitinase AC and B have more selective substrate ranges. If cell migration, adhesion, or matrix binding changes after treatment, mechanism confirmation should be further supported by proteoglycan core protein analysis and disaccharide composition analysis.

(3) Hyaluronidase

Hyaluronidase degrades hyaluronan-related matrix and is suitable for studying glycocalyx thickness, extracellular matrix barriers, CD44 binding, and cell migration. Hyaluronan is usually not covalently linked directly to membrane proteins, but it can form a cell surface glycan microenvironment through receptors and surrounding matrix.

Table 3 Common Enzymes for Cell Surface Glycan Validation and Their Application Positioning

Enzyme type	Target structure	Main use	Interpretation focus
PNGase F	Most N-glycans	N-glycan release, glycoprotein deglycosylation	Suitable for lysates or purified proteins; should not directly replace surface detection
Endo H	High-mannose N-glycans	Assess glycoprotein maturation status	Endo H sensitivity suggests insufficient glycan maturation
O-glycosidase	Some core O-glycans	O-glycan structural validation	Often requires prior desialylation
Neuraminidase	Terminal sialic acid	Validate sialylation signals	Need to distinguish broad-spectrum and linkage-specific enzymes
α-L-Fucosidase	Terminal fucose	Validate fucosylation signals	Core fucose requires more specific validation
β-Galactosidase	β-Galactose	Validate galactose-related lectin signals	Should be combined with PNA, RCA, ECL, and other probes
Heparinase	Heparin/heparan sulfate	Validate HS-dependent ligand binding	Need to consider different sulfated regions
Chondroitinase	Chondroitin sulfate/dermatan sulfate	Validate CS/DS-related functions	Should be combined with proteoglycan and matrix analysis
Hyaluronidase	Hyaluronan	Analyze hyaluronan matrix and glycocalyx function	Need to distinguish matrix effects from cell membrane effects

4 Cell Surface Glycan Detection and Enzyme Treatment Strategies

4.1 Lectin Probe Detection

(1) Flow cytometry

Fluorescently labeled lectins are suitable for detecting surface glycan intensity at the cell population level and can be combined with CD markers, viability dyes, and cell subset markers. When studying immune cells, tumor cells, or stem cell differentiation states, flow cytometry can rapidly compare glycan modification differences among different cell populations.

(2) Fluorescence imaging

Lectin fluorescence staining can reveal the spatial distribution of glycans on the cell membrane, cell junctions, pseudopodia, membrane protrusions, or extracellular vesicle surfaces. If the research target is cell surface glycans, non-permeabilized conditions should be used whenever possible to avoid interference from Golgi and endoplasmic reticulum glycoprotein signals.

(3) Lectin blotting and lectin arrays

Lectin blotting can be used to analyze glycan-binding patterns of total membrane proteins or specific proteins, while lectin arrays are suitable for screening glycan changes in samples. These methods are suitable for discovering differences, but they are not appropriate for directly defining complete glycan structures. Subsequent validation with glycosidase treatment or mass spectrometry is still required.

Table 4 Common Lectin Probes and Enzymatic Validation Strategies

Lectin	Main recognition direction	Recommended validation enzyme	Interpretation point
SNA	α2,6 sialic acid-related structures	Neuraminidase, α2,6-specific sialidase	Signal reduction supports α2,6 sialic acid dependency
MAL II	α2,3 sialic acid-related structures	Neuraminidase, α2,3-specific sialidase	Cell state and background binding should be excluded
AAL	Fucosylated structures	α-L-Fucosidase	Reflects fucosylation trend; cannot distinguish core and terminal fucose alone
UEA-I	α1,2 fucose-related structures	α-L-Fucosidase	Should be interpreted with blood group antigen background
PNA	Galβ1-3GalNAc-related structures	Neuraminidase, O-glycosidase	Increased PNA after desialylation often indicates T antigen exposure
ConA	Mannose/high-mannose N-glycans	Endo H, α-mannosidase	Suitable for preliminary screening of N-glycan maturation
WGA	GlcNAc and sialic acid-related structures	Neuraminidase, HexNAc hydrolase	Broad specificity; interpretation requires caution
RCA/ECL	Galactose-related structures	β-Galactosidase	Can assist in analyzing terminal galactose exposure

4.2 Enzyme Treatment Experimental Design

(1) Paired detection before and after treatment

Glycosidase treatment should use paired detection before and after treatment from the same batch of cells to avoid false changes caused by differences in cellular state. Cell viability, membrane integrity, and total protein expression should be recorded after treatment, especially when migration, adhesion, or immune co-culture experiments are performed afterward.

(2) Enzyme concentration and time gradients

Different enzymes vary greatly in their accessibility to live cell surface substrates. A single treatment condition cannot prove that the enzymatic reaction is sufficient. Enzyme concentration and time gradients are recommended, and reaction efficacy should be confirmed by lectin signals, glycan antibodies, or product detection.

(3) Combined enzyme treatment

Complex glycans often require combined treatment with multiple enzymes. For example, O-glycosidase action may require prior removal of sialic acid by neuraminidase; in glycosaminoglycan research, a combination of heparinase I, II, and III can cover more HS regions. Combined enzyme treatment strengthens validation, but also complicates interpretation, so single-enzyme controls are required.

4.3 Mass Spectrometry and Glycoproteomics

(1) Released glycan mass spectrometry

After N-glycans or O-glycans are released, LC-MS analysis can provide information on glycan composition, branching, and modification. This method is suitable for comparing global glycan structural changes under different treatment conditions, but it cannot directly indicate which membrane protein a glycan belongs to.

(2) Glycopeptide mass spectrometry

Glycopeptide mass spectrometry can assign glycan structures to specific protein sites and is an important method for connecting cell surface glycan changes with functional receptor regulation. If the study focuses on receptor signaling, immune checkpoints, or adhesion molecule glycosylation, glycopeptide analysis is more informative than total glycan analysis alone.

5 Functional Mechanism Research and Result Interpretation

5.1 Cell Adhesion and Migration

Cell surface glycans can regulate integrins, selectin ligands, adhesion molecules, and extracellular matrix binding. Increased sialylation can enhance surface negative charge and steric repulsion. Fucosylated Lewis structures can affect selectin-mediated cell rolling. Glycosaminoglycan chains can influence migration through matrix binding and growth factor enrichment. In migration experiments, cell proliferation and viability should be measured simultaneously to avoid misinterpreting proliferation differences as altered migration capacity.

5.2 Receptor Signaling and Membrane Localization

Glycosylation can affect membrane receptor folding, surface expression, ligand binding, and endocytic degradation. When certain N-glycan branches are enhanced, receptors may be retained longer on the cell surface through the Galectin lattice. Changes in sialylation or fucosylation may also alter receptor conformation and ligand affinity. When studying these issues, total protein expression should be distinguished from cell surface expression. Non-permeabilized flow cytometry staining, surface biotinylation, or membrane protein enrichment can be used for validation.

5.3 Immune Recognition and Immune Escape

Tumor cell surface sialylation, abnormal O-glycoantigens, and thickened glycocalyx are often associated with immune escape. Sialylated glycans can bind Siglec receptors and inhibit immune cell activation. Abnormal glycoantigens such as Tn and sTn can alter antibody recognition and immune responses. To prove that glycans participate in immune regulation, glycan signals, immune cell killing, cytokine release, immune synapse formation, and receptor-ligand binding should be assessed together.

5.4 Pathogen Binding and Infection

Many viruses, bacterial toxins, and adhesion factors depend on host cell surface glycans for binding. Sialic acid, heparan sulfate, fucosylated structures, and specific glycolipids may all participate in pathogen attachment. Glycosidase treatment can be used to verify whether infection depends on specific glycans, but attachment, entry, replication, and cell damage should be distinguished to avoid misinterpreting reduced early binding as inhibition of the entire infection process.

6 Selection of Enzymes Related to Cell Surface Glycan Modification

Table 5 Enzyme Products Related to Cell Surface Glycan Modification Research

Cat. No.	Product Name	Grade/Specification	Product Category	Application Positioning
rp227280	PNGase F (Glycerol-free) (MS)	Animal Free,Carrier Free,Bioactive,Recombinant,suitable for mass spectrometry (MS),ActiBioPure™,EnzymoPure™,for protein sequencing,≥95%(SDS-PAGE)	N-glycan release enzyme	Used for N-glycan release, glycoprotein deglycosylation, mass spectrometry pretreatment, and analysis of N-glycan structures on cell surface glycoproteins
rp227283	PNGase F (MS)	Animal Free, Carrier Free, Bioactive, Recombinant, suitable for mass spectrometry (MS), ActiBioPure™, EnzymoPure™, for protein sequencing, ≥95%(SDS-PAGE), 100000 U/mL	N-glycan release enzyme	Used for membrane glycoprotein N-glycan release, glycomics analysis, and glycopeptide MS sample preparation
N755142	N-Glycosidase F, Elizabethkingia meningosepticum	≥20,000 units/mg protein ≥4500 units/mL	N-glycan release enzyme	Used for glycoprotein N-glycan removal and deglycosylation validation
P293505	Peptide-N4-(N-acetyl-β-glucosaminyl) asparagineamidase	EnzymoPure™, 50U/μL	N-glycan release enzyme	Used for N-linked glycan release, glycoprotein deglycosylation, and N-glycosylation structural validation
P755183	PNGase F from Elizabethkingia miricola	buffered aqueous solution	N-glycan release enzyme	Used for N-glycan release and glycoprotein deglycosylation experiments
P755191	PNGase F from Elizabethkingia meningoseptica	BioReagent, Proteomics grade, ≥95%(SDS-PAGE)	Proteomics-grade N-glycan release enzyme	Used for glycoproteomics, N-glycan release, and MS sample processing
P755115	Recombinant PNGase F	Bioactive,ActiBioPure™,High Performance,EnzymoPure™,His Tag,≥95%(SDS-PAGE&SEC-HPLC),≥30000U/mg protein	Recombinant N-glycan release enzyme	Used for N-glycan release from glycopeptides and glycoproteins, supporting glycoprotein structural analysis
G755042	Glycopeptidase A from almonds	buffered aqueous glycerol solution,≥0.05 unit/mL	Glycopeptide hydrolase	Used for glycopeptide-related structural processing and auxiliary glycan analysis
E755089	Endoglycosidase H, Streptomyces plicatus, Recombinant, E. coli	Endoglycosidase H, <i>Streptomyces plicatus</i>, Recombinant, <i>E. coli</i> cleaves between the two N-acetylglucosamine residues in the diacetylchitobiose core of the oligosaccharide.	N-glycan endoglycosidase	Used for cleavage of high-mannose and some hybrid N-glycans, and assessment of glycoprotein maturation status
E755099	Endoglycosidase H from Streptomyces plicatus	Recombinant, expressed in <I>E. coli</I>, buffered aqueous solution	N-glycan endoglycosidase	Used for Endo H sensitivity analysis to distinguish immature N-glycans from complex N-glycans
O755132	Recombinant O-Glycosidase	Bioactive,ActiBioPure™,High Performance,EnzymoPure™,His Tag,≥10000U/mg protein	O-glycan cleavage enzyme	Used for mucin-type O-glycan structural validation and O-glycosylation research
rp227296	Recombinant O-Glycosidase (MS Grade)	Animal Free,Carrier Free,Bioactive,suitable for mass spectrometry (MS),ActiBioPure™,for protein sequencing,His Tag,≥90%(SDS-PAGE),≥40000U/μl	MS-grade O-glycan cleavage enzyme	Used for O-glycan release, glycoprotein MS pretreatment, and O-glycosylation structural analysis
R1441500	Recombinant endoglycoceramidase I		Glycolipid glycan endoglycosidase	Used for ganglioside glycan cleavage, cell membrane glycolipid structure research, and glycolipid-related surface recognition analysis
R405899	rEGCase II	EnzymoPure™, 2000 MU/ml	Glycolipid glycan endoglycosidase	Used for ganglioside-related glycan processing and cell surface glycolipid function research
R1444002	Recombinant endoglycoceramidase I assisted by activator II		Glycolipid glycan endoglycosidase	Used for ganglioside glycan structural analysis and glycolipid-dependent recognition mechanism research
R1437134	Recombinant endoglycoceramidase II assisted by activator II		Glycolipid glycan endoglycosidase	Used for membrane glycolipid glycan cleavage and ganglioside-related functional validation
N755087	α(2→3,6,8,9) Neuraminidase from Arthrobacter ureafaciens	Proteomics grade, suitable for MALDI-TOF MS	Broad-spectrum neuraminidase	Used to remove α2-3, α2-6, α2-8, and α2-9-linked sialic acids and validate cell surface sialylation signals
N755068	α(2→3,6,8,9) Neuraminidase from Arthrobacter ureafaciens	Recombinant, expressed in <I>E. coli</I>, buffered aqueous solution	Broad-spectrum neuraminidase	Used to validate SNA, MAL II, and other sialic acid-related lectin signals
rp227304	Sialidase (a2-3,6,8,9)	Animal Free,Carrier Free,Bioactive,Recombinant,suitable for mass spectrometry (MS),ActiBioPure™,EnzymoPure™,for protein sequencing,≥95%(SDS-PAGE),≥50U/μL; expressed in E.coli	MS-grade broad-spectrum sialidase	Used for glycoprotein/glycopeptide desialylation, MS pretreatment, and cell surface sialylation structural validation
rp227302	Sialidase (a2-3,6,8)	Animal Free,Carrier Free,Bioactive,Recombinant,suitable for mass spectrometry (MS),ActiBioPure™,EnzymoPure™,for protein sequencing,≥95%(SDS-PAGE),≥50U/μL; expressed in E.coli	Recombinant sialidase	Used for cleavage of α2-3, α2-6, and α2-8 sialic acid-related structures and glycomics analysis
N755031	α(2→3,6) Neuraminidase from Clostridium perfringens (C. welchii)	Recombinant, expressed in <I>E. coli</I>, buffered aqueous solution,≥250 units/mg protein	α2-3/α2-6 neuraminidase	Used to distinguish and validate α2-3/α2-6 sialylation-related cell surface signals
N755050	α(2→3) Neuraminidase from Streptococcus pneumoniae	buffered aqueous solution	α2-3 neuraminidase	Used for α2-3 sialylation structural validation, suitable for MAL II signals and pathogen receptor research
N755661	α2-3,6-Neuraminidase, Clostridium perfringens, Recombinant, E. coli		α2-3/α2-6 neuraminidase	Used for removal of cell surface sialylated glycans and linkage-related validation
N774058	Neuraminidase (NRH)	EnzymoPure™, Bioactive, ActiBioPure™, High Performance, ≥90%(SDS-PAGE), ≥300 U/mg protein	Neuraminidase	Used for sialic acid removal, glycan remodeling, and cell surface negative charge barrier research
N128390	Neuraminidase from Clostridium perfringens	EnzymoPure™, ≥0.5 units/mg dry weight	Neuraminidase	Used for cell surface desialylation and validation of sialic acid-dependent functions
N128387	Neuraminidase from Clostridium perfringens(Purified)	EnzymoPure™, ≥10 units/mg protein	Purified neuraminidase	Used for sialylated glycan validation and neuraminidase treatment controls
N755172	Neuraminidase from Clostridium perfringens (C. welchii)	Type X, lyophilized powder,≥50 units/mg protein (using 4MU-NANA)	Neuraminidase	Used for high-activity sialic acid removal and functional validation of cell surface glycans
N755049	Neuraminidase from Clostridium perfringens (C. welchii)	Type VIII, lyophilized powder, 10-20 units/mg protein (using 4MU-NANA), 3.5-8.0 units/mg protein (mucin)	Neuraminidase	Used for processing mucin-type glycans and cell surface sialic acid-related structures
N755098	Neuraminidase from Clostridium perfringens (C. welchii)	Type VI, lyophilized powder, 6-15 units/mg protein (using 4MU-NANA), 2-10 units/mg protein (mucin)	Neuraminidase	Used for sialylated glycoprotein processing and lectin signal validation
N755202	Neuraminidase from Vibrio cholerae	sterile-filtered, Type III, buffered aqueous solution, 1-5 units/mg protein (Lowry, using NAN-lactose)	Neuraminidase	Used for cell surface sialic acid removal and pathogen receptor-related glycan research
N755091	Neuraminidase from Vibrio cholerae	Type II, buffered aqueous solution, 8-24 units/mg protein (Lowry, using NAN-lactose)	Neuraminidase	Used for glycoprotein desialylation and sialic acid-dependent cell recognition research
A1435450	alpha-2-3,6-sialidase (BiNanH2)		Sialidase	Used for α2-3/α2-6 sialylated structure cleavage and linkage validation
G1444891	Ganglioside sialidase (AuSialidase M2)		Glycolipid sialidase	Used for ganglioside desialylation and cell surface glycolipid function research
G1437390	Ganglioside sialidase (AuSialidase S)		Glycolipid sialidase	Used for validation of ganglioside-related sialic acid structures
N489858	Neuraminidase Au	Specific Activity ＞135 U/mg;Activity＞5 U/ml	Neuraminidase	Used for sialylated glycan cleavage and optimization of enzyme treatment conditions
N489868	Neuraminidase Cp	Specific Activity ＞250 U/mg;Activity 15 U/ml	Neuraminidase	Used for cell surface sialylation validation and glycan remodeling experiments
N489878	Neuraminidase Sp	Specific Activity ≥ 250 U/mg;Activity ≥ 10 U/ml	Neuraminidase	Used for sialylated structure processing and lectin signal validation
rp223124	Recombinant α1, 2-fucosidase (BbAfcA)	Bioactive,ActiBioPure™,High Performance,EnzymoPure™,His Tag,≥90%(SDS-PAGE),≥10 U/mg protein	α1,2-Fucosidase	Used for cleavage of α1,2 fucose-related structures and validation of H antigen and UEA-I-related signals
F477365	α-1,2-Fucosidase solution	buffered aqueous solution	α1,2-Fucosidase	Used for terminal α1,2 fucose removal and validation of fucosylated structures
F755030	α1-3,4-Fucosidase, Xanthomonas sp.	Native α1-3,4-fucosidase from Xanthomonas species. Catalyzes the hydrolysis of α1,3- and α1,4-linked branched, non-reducing terminal fucose from complex carbohydrates. Note: 1 mU = 1 milliunit.	α1,3/α1,4-Fucosidase	Used for processing Lewis/sLeX-related terminal fucose structures and selectin ligand research
F755038	Recombinant α-1,6-Fucosidase (LpAlfC)	Bioactive,ActiBioPure™,High Performance,EnzymoPure™,His Tag,≥90%(SDS-PAGE),≥500 U/mg protein	α1,6-Fucosidase	Used for removal of core fucosylation-related structures and FUT8 pathway functional validation
rp223165	Recombinant α1-3,4 Fucosidase (BbAfcB)	Bioactive,Recombinant,ActiBioPure™,High Performance,EnzymoPure™,His Tag,≥90%(SDS-PAGE),≥2U/mg protein; protein concentration: 5-10mg/ml	α1,3/α1,4-Fucosidase	Used for terminal fucose removal, Lewis antigen-related glycan analysis, and lectin signal validation
E755085	Recombinant Endo-β-galactosidase (BfEndoβGal)	Bioactive,ActiBioPure™,High Performance,EnzymoPure™,His Tag,≥1000 U/mg protein	Endo-β-galactosidase	Used for processing poly-LacNAc/LacNAc-related structures and Galectin-binding mechanism research
G755072	β-Galactosidase (GAL)	Native,≥80%(SDS-PAGE),≥0.15 U/mg protein; Protein ≥40%, Originating from bovine liver	β-Galactosidase	Used for terminal β-galactose removal and validation of RCA, ECL, PNA, and other galactose-related signals
G755128	β-Galactosidase (GAL)	Bioactive,ActiBioPure™,High Performance,EnzymoPure™,Recombinant,≥80%(SDS-PAGE),≥ 400 U/mg protein	Recombinant β-galactosidase	Used for cell surface galactosylated structure processing and glycan function validation
G755154	β-Galactosidase (GAL)	Derived from Grade VI Escherichia coli, Lyophilized Powder, ≥ 250 units/mg protein	β-Galactosidase	Used for β-galactose residue removal and lectin-binding site validation
G755189	β-Galactosidase (GAL)	8.0 units/mg solid,Derived from Aspergillus oryzae	β-Galactosidase	Used for galactose residue removal and terminal glycan structure analysis
G493781	β-Galactosidase (GAL)	EnzymoPure™,150000u/g, Derived from Aspergillus oryzae	High-activity β-galactosidase	Used for β-galactose-related glycan processing and optimization of enzymatic digestion conditions
G755121	α-Galactosidase from green coffee beans	ammonium sulfate suspension,≥9 units/mg protein	α-Galactosidase	Used for α-Gal-related structure removal and analysis of cell surface galactosylation differences
G304917	α-galactosidase from Aspergillus niger	EnzymoPure™, 2000U/g	α-Galactosidase	Used for α-galactose residue processing and glycan structural validation
G755079	α-Galactosidase, positionally specific from Escherichia coli	Recombinant, expressed in <I>E. coli</I>, buffered aqueous solution	Positional-specific α-galactosidase	Used for α-Gal-related glycan site validation and structural analysis
N755111	β-N-Acetylglucosaminidase from Canavalia ensiformis (Jack bean)	EnzymoPure™,ActiBioPure™,Bioactive,High Performance,Native,ammonium sulfate suspension, ≥10 U/mg protein; Protein content: 1-5 mg/ml	HexNAc hydrolase	Used for terminal GlcNAc/GalNAc-related structure processing and auxiliary interpretation of WGA signals
N774090	β-N-Acetylhexosaminidase (NAG) from Porcine kidney	Bioactive, ActiBioPure™, High Performance, EnzymoPure™, 10 U/mL	β-N-Acetylglucosaminidase	Used for HexNAc terminal hydrolysis and auxiliary glycan structural validation
M755138	α-Mannosidase from Canavalia ensiformis (Jack bean)	ammonium sulfate suspension,≥15 units/mg protein (biuret)	α-Mannosidase	Used for high-mannose N-glycan modification analysis and ConA signal validation
M755088	β-Mannosidase from Helix pomatia	5-30 units/mL, ammonium sulfate suspension, crude extract	β-Mannosidase	Used for mannose-related glycan structural analysis and validation of specific glycoprotein glycans
H766335	Heparinase I	Bioactive, ActiBioPure™, EnzymoPure™, High Performance, ≥90%(SDS-PAGE), ≥6000 U/mL	Glycosaminoglycan lyase	Used for degrading highly sulfated heparin/heparan sulfate regions and validating HS-dependent ligand binding and viral attachment
H766338	Heparinase II	Bioactive,ActiBioPure™,High Performance,EnzymoPure™,≥90%(SDS-PAGE),≥2400 U/mL for 25U and 100U; ≥240 U/mL for 10U	Glycosaminoglycan lyase	Used for broad cleavage of heparin/heparan sulfate structures and evaluation of cell surface HS function
H766341	Heparinase III	Bioactive,ActiBioPure™,High Performance,EnzymoPure™,≥90%(SDS-PAGE),≥3000 U/mL for 50U; ≥300 U/mL for 5U and 10U	Glycosaminoglycan lyase	Used for analysis of low-sulfated heparan sulfate regions and HS structural domain studies
H766347	Heparinase I and III blend	EnzymoPure™, ≥200(U/mg), from Flavobacterium heparinum	Heparinase mixture	Used for degrading different HS regions on cell surfaces
H766343	Heparinase I, II and III blend	EnzymoPure™, ≥200(U/mg), from Flavobacterium heparinum	Heparinase mixture	Used for broader degradation of heparin/heparan sulfate and validation of HS-dependent cell surface functions
H1435491	Heparanase 1, Human		Heparanase/HPSE	Used for heparan sulfate remodeling, tumor invasion, and extracellular matrix degradation research
EJ1513769	Human Heparanase(HPA) ELISA Kit	BioReagent	HPSE protein detection	Used to detect heparanase levels in human samples and evaluate HS degradation-related mechanisms
EJ1512952	Mouse Heparanase (HPSE) ELISA Kit	BioReagent	HPSE protein detection	Used for HPSE detection in mouse models, supporting glycosaminoglycan remodeling and tumor/inflammation research
C755225	Chondroitinase ABC from Proteus vulgaris	lyophilized powder, 0.3-3 units/mg solid	Chondroitin/dermatan lyase	Used for degrading chondroitin sulfate and dermatan sulfate and validating CS/DS-related adhesion, migration, and matrix functions
C766313	Chondroitinase ABCI	EnzymoPure™, ≥50(IU/mg), from Proteus vulgaris	Chondroitinase ABC	Used for CS/DS chain degradation and proteoglycan functional validation
C766319	Chondroitinase ABC II	Bioactive,Recombinant,ActiBioPure™,High Performance,EnzymoPure™,expressed in E.coli; ≥1000 U/mg enzyme powder; ≥2000 U/mg protein	Recombinant chondroitinase ABC	Used for efficient CS/DS cleavage, disaccharide composition analysis, and cell surface proteoglycan research
C755146	Chondroitinase AC	Bioactive,Recombinant,ActiBioPure™,High Performance,EnzymoPure™,≥95%(SDS-PAGE),≥100 U/mg enzyme powder; ≥200 U/mg protein	Chondroitinase AC	Used for selective processing of chondroitin sulfate A/C-related structures
C766326	Chondroitinase AC II	EnzymoPure™, ≥20IU/mg, from Arthrobacter aurescens	Chondroitinase AC	Used for CS-A/CS-C structure degradation and glycosaminoglycan composition analysis
C766331	Chondroitinase C	EnzymoPure™, ≥2000U/mg, from Flavobacteriun heparinum	Chondroitinase C	Used for processing specific chondroitin sulfate structures and GAG analysis
H304866	Hyaluronidase from Bovine Testes	EnzymoPure™, ≥400 u/mg	Hyaluronan-degrading enzyme	Used for degrading hyaluronan matrix and analyzing glycocalyx thickness, CD44-related binding, and cell migration
K758740	Keratanase II	EnzymoPure™, ≥50UN/mg, from Bacillus circulans	Keratan sulfate lyase	Used for keratan sulfate structural processing and extracellular matrix glycan analysis
N1442045	N-Acetylgalactosamine-6-Sulfatase		Glycosaminoglycan sulfatase	Used for removal of GalNAc-6 sulfate groups and structural analysis of sulfated glycans
U758725	Unsaturated hexuronate-2-O-sulfatase	EnzymoPure™, ≥50UN/mg, from Bacteroidetes	Glycosaminoglycan sulfatase	Used for analysis of GAG disaccharide sulfation structures and sulfation sites
I1433229	Iduronate sulfatase		Glycosaminoglycan sulfatase	Used for studies of sulfation structures related to heparan sulfate/dermatan sulfate
S755124	α-2,3-Sialyltransferase from Pasteurella multocida	Recombinant, expressed in <I>E. coli</I> BL21,≥2 units/mg protein	Sialyltransferase	Used for in vitro construction of α2-3-sialylated glycans and validation of MAL II-related signals
S755123	α-2,6-Sialyltransferase from Photobacterium damsela	Recombinant, expressed in <I>E. coli</I> BL21,≥5 units/mg protein	Sialyltransferase	Used for in vitro α2-6 sialylation modification and validation of SNA binding and Siglec-related studies
A1439306	alpha-2,8-Sialyltransferase (CstII)		Sialyltransferase	Used for α2-8 sialylation or polysialic acid-related structure research
S1439868	ST6 Sialyltransferase 1		ST6GAL transferase	Used for α2-6 sialylation modification and cell surface immune recognition research
S1443897	ST6 Sialyltransferase 4		ST6GAL transferase	Used for construction of α2-6 sialylation-related glycans
S1428985	ST6 Sialyltransferase 5		ST6GAL transferase	Used for sialylated glycan synthesis and surface glycan terminal modification research
S1435515	ST8 alpha-2,8-Sialyltransferase 4		ST8SIA transferase	Used for α2-8 sialylation and polysialic acid-related structure research
S1435785	ST8 alpha-2,8-Sialyltransferase 6		ST8SIA transferase	Used for α2-8 sialylated glycan synthesis research
S1437527	ST8 alpha-2,8-Sialyltransferase 8B		ST8SIA transferase	Used for cell surface glycans related to polysialic acid research
G293642	α-1,4-Galactosyltransferase	EnzymoPure™, ≥95%(SDS-PAGE)	Galactosyltransferase	Used for α1,4 galactosylated structure construction and galactosylated glycan research
B1431047	beta-1,3-Galactosyltransferase (CgtB)		Galactosyltransferase	Used for β1,3 galactosylation reactions and glycan extension research
B755120	Beta-1,4-galactosyltransferase 1	Bioactive,Recombinant,ActiBioPure™,High Performance,EnzymoPure™,His Tag,expressed in Baculovirus-BTI-TN-5B1-4 Cells; >2000 U/mg protein; Protein concentration: See COA	β1,4-Galactosyltransferase	Used for LacNAc extension, galactosylated glycan construction, and Galectin-binding mechanism research
B1438840	Beta-1,4-Galactosyltransferase 1 (Y285L)	Bioactive,Recombinant,ActiBioPure™,High Performance,EnzymoPure™,His Tag,expressed in HEK293; >1000 U/mg protein; Protein concentration: See COA	β1,4-Galactosyltransferase mutant	Used for galactosyltransfer reactions, glycoengineering, and terminal glycan modification research
B1507859	Bovin beta-1,4-galactosyltransferase 1	Bioactive,Recombinant,ActiBioPure™,High Performance,EnzymoPure™,His Tag,expressed in Baculovirus-BTI-TN-5B1-4 Cells;  >2000 U/mg protein; Protein concentration: See COA	β1,4-Galactosyltransferase	Used for β1,4 galactosylation and in vitro glycan extension
B1443293	Bovin beta-1,4-galactosyltransferase 1 (Y289L)	Bioactive,Recombinant,ActiBioPure™,High Performance,EnzymoPure™,His Tag,expressed in HEK293; >1000 U/mg protein; Protein concentration: See COA	β1,4-Galactosyltransferase mutant	Used for glycoengineering and galactosylation modification research
M1507860	Mouse Beta-1,4-galactosyltransferase 1 (Y286L)	Bioactive,Recombinant,ActiBioPure™,High Performance,EnzymoPure™,His Tag,>2000 U/mg protein; Protein concentration: See COA ; expressed in HEK293	β1,4-Galactosyltransferase mutant	Used for mouse-related glycan modification models and in vitro galactosylation reactions
G1439963	β-1,4-Galactosyltransferase, neisseria meningitides		Galactosyltransferase	Used for β1,4 galactosylated glycan construction
G1444770	Galactosyltransferase		Galactosyltransferase	Used for galactosylated glycan extension and in vitro glycan synthesis
U1446093	UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2		GalNAc transferase	Used for N-acetylgalactosamine-related glycan extension and O-glycan structural research
N1433283	N-Acetylglucosaminyltransferase IVa		GlcNAc transferase	Used for N-glycan branching and complex glycan construction research
N1419146	α-1,4-N-Acetylglucosaminyltransferase 4		GlcNAc transferase	Used for α1,4-GlcNAc-related structure construction and glycan modification research
EJ1513699	Human Beta-1,4-mannosyl-glycoProtein 4-beta-N-acetylglucosaminyltransferase (MGAT3) ELISA Kit	BioReagent	MGAT3 detection product	Used to detect MGAT3 levels in human samples and evaluate mechanisms related to N-glycan branching regulation

7 Common Questions

7.1 Why should enzymes be emphasized in cell surface glycan modification research?

Glycan structures are jointly determined by glycosyltransferases, glycosidases, nucleotide sugar donors, and organelle localization. Detecting glycan signals alone only indicates that surface structures have changed. Combining this with related enzyme expression, enzyme treatment, or enzyme activity validation can further clarify the cause and functional significance of glycan changes.

7.2 Does a change in lectin signal equal a change in one specific glycan structure?

Not completely. Lectins recognize a class of glycan features or binding sites, not complete glycan structures. Lectin signals are suitable for screening and comparing trends. To confirm specific glycan structures, glycosidase treatment, glycan competition experiments, glycoantigen antibodies, or mass spectrometry analysis should be combined.

7.3 What does a decrease in lectin signal after neuraminidase treatment indicate?

If sialic acid-related lectin signals such as SNA and MAL II decrease after neuraminidase treatment, it indicates that the signal is sialic acid-dependent. However, linkage-specific enzymes, cell viability, and surface protein expression should still be assessed to determine whether the change involves α2,3, α2,6, or broader sialylation.

7.4 Can PNGase F be used directly to validate N-glycans on live cell surfaces?

It is usually not the preferred approach. PNGase F is more suitable for lysates, purified glycoproteins, or glycomics pretreatment. Live cell surface treatment may be limited by substrate accessibility, membrane state, and enzyme reaction conditions. If the target is surface N-glycans, non-permeabilized flow cytometry, membrane protein enrichment, and mass spectrometry analysis are recommended.

7.5 Does reduced cell migration after glycosidase treatment necessarily mean that the target glycan promotes migration?

Not necessarily. Glycosidase treatment may simultaneously alter glycans on multiple membrane proteins, cell surface charge, adhesion state, and cell viability. Heat-inactivated enzyme controls, viability assays, target glycan signal validation, and gene intervention experiments are required to more reliably support a causal relationship.

Cell surface glycan modification research should follow the line of “glycan structure—related enzyme—surface localization—functional phenotype.” Glycosyltransferases determine the direction of glycan formation, while glycosidases and glycosaminoglycan lyases are used for structural validation and functional intervention. Lectins, glycan antibodies, and mass spectrometry provide evidence at different levels.

For more related articles, please see below:

[1] Molecular Mechanisms of Glycosylation-Mediated Regulation of Cell Surface Signaling